CN Patent
CN1087626A — 新颖的7-(取代)-8-(取代)-9-[(取代的甘氨酰)酰氨基]-6-去甲基-6-去氧四环素
Assigned to Wyeth Holdings LLC · Expires 1994-06-08 · 32y expired
What this patent protects
本发明提供了式I化合物。 其中R,R 3 ,R 4 ,X和W如说明书中所定义。这 些化合物作为抗生素是有用的。
USPTO Abstract
本发明提供了式I化合物。 其中R,R 3 ,R 4 ,X和W如说明书中所定义。这 些化合物作为抗生素是有用的。
Drugs covered by this patent
- Xerava (ERAVACYCLINE DIHYDROCHLORIDE) · Tetraphase Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.